WGS logo

WGS
GeneDx Holdings Corp

4,491
Mkt Cap
$2.01B
Volume
457,193.00
52W High
$170.87
52W Low
$55.17
PE Ratio
-92.36
WGS Fundamentals
Price
$68.53
Prev Close
$66.24
Open
$66.40
50D MA
$74.06
Beta
1.39
Avg. Volume
798,412.58
EPS (Annual)
-$0.7339
P/B
6.50
Rev/Employee
$328,876.15
$3,667.03
Loading...
Loading...
News
all
press releases
Peregrine Capital Management LLC Reduces Stock Holdings in GeneDx Holdings Corp. $WGS
Peregrine Capital Management LLC decreased its position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 27.2% during the 4th quarter, according to the company in its most recent disclosure...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Rating of "Moderate Buy" from Analysts
GeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the nine ratings firms that are currently covering the firm, Marketbeat Ratings...
MarketBeat·8d ago
News Placeholder
GeneDx Holdings Corp. $WGS Shares Purchased by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 30.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 381,725 shares of the company's stock a...
MarketBeat·11d ago
News Placeholder
Cathie Wood's Ark keeps selling one stock once again
Cathie Wood, head of Ark Investment Management, is known for making bold, conviction-driven bets, but she's just as quick to trim positions when the strategy shifts. That pattern is playing out again...
TheStreet.com·12d ago
News Placeholder
GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will release financial results for the first quarter of 2026...
Business Wire·13d ago
News Placeholder
Three Best Genomics Stocks for Your Portfolio in 2026
Genomics gains momentum as breakthroughs, falling sequencing costs, and CRISPR advances drive precision medicine and fuel rapid market growth.
Zacks·14d ago
News Placeholder
GeneDx (NASDAQ:WGS) Stock Price Down 8.9% - Here's Why
GeneDx (NASDAQ:WGS) Stock Price Down 8.9% - Time to Sell...
MarketBeat·17d ago
News Placeholder
CNC Combines Its North Carolina Units to Expand Statewide Footprint
Centene merges its North Carolina units into Carolina Complete Health and aims to streamline Medicaid operations while serving over 980,000 members statewide.
Zacks·20d ago
News Placeholder
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 46,933 Shares
GeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 46,933 shares of the business's stock in a transaction on Thursday, March 26th. The shares were sold at an average price of $63.17, for a total transaction of $2,964,757.61. Following the sale, the chief executive...
MarketBeat·25d ago
News Placeholder
New Strong Buy Stocks for April 2nd
DNUT, GCT, WGS, VSNT and FLOC have been added to the Zacks Rank #1 (Strong Buy) List on April 2nd, 2026.
Zacks·25d ago
<
1
2
...
>

Latest WGS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.